Bioassay-guided discovery of antibacterial agents: in vitro screening of Peperomia vulcanica, Peperomia fernandopoioana and Scleria striatinux by unknown
Mbah et al. Annals of Clinical Microbiology and Antimicrobials 2012, 11:10
http://www.ann-clinmicrob.com/content/11/1/10RESEARCH Open AccessBioassay-guided discovery of antibacterial agents:
in vitro screening of Peperomia vulcanica,
Peperomia fernandopoioana and Scleria striatinux
James A Mbah1, Moses N Ngemenya2*, Ashime Louis Abawah2, Smith B Babiaka1, Lina N Nubed1,
Kennedy D Nyongbela1, Njimoh Dieudonne Lemuh2 and Simon MN Efange1Abstract
Background: The global burden of bacterial infections is high and has been further aggravated by increasing
resistance to antibiotics. In the search for novel antibacterials, three medicinal plants: Peperomia vulcanica,
Peperomia fernandopoioana (Piperaceae) and Scleria striatinux (Cyperaceae), were investigated for antibacterial
activity and toxicity.
Methods: Crude extracts of these plants were tested by the disc diffusion method against six bacterial test
organisms followed by bio-assay guided fractionation, isolation and testing of pure compounds. The minimum
inhibitory (MIC) and minimum bactericidal (MBC) concentrations were measured by the microdilution method. The
acute toxicity of the active extracts and cytotoxicity of the active compound were performed in mice and
mammalian cells, respectively.
Results: The diameter of the zones of inhibition (DZI) of the extracts ranged from 7–13 mm on Escherichia coli and
Staphylococcus aureus of which the methylene chloride:methanol [1:1] extract of Scleria striatinux recorded the
highest activity (DZI = 13 mm). Twenty-nine pure compounds were screened and one, Okundoperoxide, isolated
from S. striatinux, recorded a DZI ranging from 10–19 mm on S. aureus. The MICs and MBCs indicated that the
Peperomias had broad-spectrum bacteriostatic activity. Toxicity tests showed that Okundoperoxide may have a low
risk of toxicity with an LC50 of 46.88 μg/mL.
Conclusions: The antibacterial activity of these plants supports their use in traditional medicine. The pure
compound, Okundoperoxide, may yield new antibacterial lead compounds following medicinal chemistry
exploration.
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Bacterial infections account for a significant proportion
of the global infectious disease burden, along with a high
morbidity and mortality [1], and impact negatively on
human welfare and the economy. Antibiotic chemother-
apy, the main tool employed against clinical infections, is
constantly threatened by increasing resistance in some
organisms [2]. This necessitates a constant search for
new antibacterials to preempt the resistance onslaught.* Correspondence: mnngemenya@yahoo.com
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medium, provided the original work is properPlants remain an important source of diverse chemical en-
tities which have been used as drugs or provide scaffolds
from which new drugs have been derived [3,4]. Conse-
quently, the screening of plants for their medicinal value
remains an active area of scientific investigation. The
present paper describes some of the results of our attempt
to discover new antibacterial drug leads from plant sources.
Antibacterial activity was demonstrated in the crude
methanol extracts of Peperomia vulcanica and Peperomia
fernandopoioana both from the Piperaceae family [5], and
Scleria striatinux De Wild (Cyperaceae) [6]. These findings
motivated our search for antibacterials from these plants.
Twenty-nine pure compounds were isolated, seven oftd. This is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
ly cited.
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matairesinol dimethyl ether (2), 5-demethyltangeretin (3),
stigmasterol (4), bursehernin (5), hexadecanoic acid (6) and
linoleic acid (7). The antibacterial activity of all the plant
secondary metabolites was evaluated and toxicity tests per-




Whole plants of P. vulcanica, Baker and C.H. Wright
and P. fernandopoioana C.D.C. were collected from
Mount Cameroon and authenticated by Mr. Ndive Elias,
a botanist in the Limbe Biodiversity and Conservation
Centre (LBCC), Cameroon. Voucher specimens NO S.C.
A. 8892 for P. vulcanica and NO S.C.A. 8786 for P. fer-
nandopoioana are available at the herbarium of LBCC.
The roots of Scleria striatinux De Wild (Cyperaceae)
were collected in the North West Region of Cameroon,
identified and assigned voucher specimen NO 32235/
HNC at the National Herbarium, Yaounde, Cameroon.
Preparation of crude extracts
Each plant material was air-dried at room temperature for
one month, chopped and ground into powder which wasFigure 1 Flow chart for the bioassay-guided fractionation and isolatio
compounds. The identified compounds are numbered as in the text. UZI =further air-dried for 3 days. Each plant powder (2.5 g of P.
vulcanica and 2 kg of P. fernandopoioana) was macerated
for 48 hours three times per solvent and successively in
hexane (6 L), methylene chloride (6 L) and methanol (par-
tially done for biological testing). The mixture was filtered,
and the filtrate concentrated by rotary evaporation. The
concentrate was recovered with a small volume of methy-
lene chloride and kept open at room temperature until all
the residual solvent had evaporated. The dried crude
extracts were weighed, and the bottles were sealed with
Parafilm and stored at 4°C. The fractionation sequences are
shown in Figures 1 and 2. For Scleria striatinux extraction
was done as reported [7].
Fractionation of extracts and isolation of pure compounds
Bioassay-guided fractionation was done only on active
crude extracts to isolate the pure compounds for further
antibacterial screening. The hexane crude extract of P. vul-
canica was fixed on Celite and fractionated using vacuum
liquid chromatography (VLC) on silica gel and eluted with
a gradient of ethyl acetate (EtOAc [0–80%]) in hexane.
Following thin layer chromatography (TLC), 8 main frac-
tions were identified (three of which were active). Fraction
3 (obtained with 10% EtOAc-hexane) was further chroma-
tographed on SiO2 with a gradient of EtOAc in hexane ton of compounds from P.vulcanica. PVs represent uncharacterized
unclear zone of inhibition.
Figure 2 Flow chart for the bioassay-guided fractionation and isolation of compounds from P. fernandopoioana. PFs represent
uncharacterized compounds. The identified compounds are numbered as in the text. UZI = unclear zone of inhibition.
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40% EtOAc-hexane) was chromatographed on SiO2 and
later passed through Sephadex LH-20 to yield 5-demethly-
tangeretin (44 mg) and white crystals of matairesinol di-
methyl ether (500 mg) as shown on Figure 1.
The hexane extract of P. fernandopoioana (66 g) was
fixed on Celite; repeated separation on silica followed by
purification on Sephadex LH-20 yielded hexadecanoic
acid (55 mg), linoleic acid and bursehernin (39 mg) as
shown on Figure 2. This purification of the hexane crude
extracts of both plants afforded a total of 20 pure pro-
ducts (8 from P. vulcanica and 12 from P. fernando-
poioana). Similarly, fractionation and purification of the
methylene chloride crude extracts using the same meth-
ods afforded 5 compounds from P. vulcanica and 2 com-
pounds from P. fernandopoioana, making a total of 20
and 7 compounds for these plants from the hexane and
methylene chloride extracts respectively.
Two compounds, one named Okundoperoxide (1 or
OKP) and the other yet to be identified, were isolated from
the CH2Cl2/MeOH (1:1) extract of S. striatinux [7].
Characterization of compounds was done using spectro-
scopic techniques and comparison of 1H and 13C Nuclear
Magnetic Resonance (NMR) data with those found in the
literature.Bacterial cells
Four bacterial species, i.e. Escherichia coli, Staphylococcus
aureus, Salmonella typhimurium, and Pseudomonas aerugi-
nosa, were isolated from pathological specimens obtained
from Solidarity Clinic, Molyko, Buea Sub-Division,
Cameroon, using selective media as described [8,9].
Identification of isolates was based on their cultural,
Gram reaction, morphological and specific biochemical
characteristics. A strain of S. aureus resistant to vanco-
mycin, ampicillin and erythromycin was also isolated. E. coli
(ATCC 11775) and S. aureus (ATCC 33862) from the
American Type Culture Collection were used as controls.
The organisms were stored at 4°C and sub-cultured weekly
during the study period.
Preparation of discs of crude extracts, fractions and pure
compounds
Extract-impregnated discs were prepared as earlier
described [10] with some modifications. Briefly, 5 mm
discs were punched from a stack of four Whatman filter
papers and autoclaved. Ten (10) μL of test solution (con-
taining 1 mg of crude extract or fraction in acetone) was
transferred onto a disc and the latter was dried in an in-
cubator at 55°C for 20 minutes. This step was repeated
four times giving discs containing 5 mg of crude extract
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pound were prepared similarly. Commercial antibiotic
discs of vancomycin (30 μg), erythromycin (15 μg), colis-
tin (10 μg) and ampicillin (10 μg) were used as positive
controls. A 5 mg/mL stock of gentamycin was diluted in
distilled water and a control disc containing 1 μg pre-
pared as described above. Negative control discs were
also prepared using 50 μL of acetone added in 10 μL ali-
quots and dried as above.
Antibacterial susceptibility test
Disc diffusion method
The disc diffusion method was used as previously
described [5,10] with some modifications. Bacterial sus-
pension (100 μL of 6 x 108 CFUs/mL in 0.85% saline
equivalent to McFarland 2) was uniformly spread on nu-
trient agar (Columbia agar base) in a culture plate. The
test, negative and positive control discs, were aseptically
fixed with gentle pressure on labeled positions on the
bacterial spread. Only fractions prepared from crude
extracts which initially showed activity in the disc test
were tested. The plates were incubated for 18–24 hours
at 37°C and the zones of inhibition measured.
Determination of minimum inhibitory concentration (MIC)
and minimum bactericidal concentration (MBC)
This was done for the most active crude extracts i.e. ac-
tive on at least two bacterial species, and the pure com-
pound which was active following the disc diffusion test.
A stock solution of crude extract (40 mg/mL) was pre-
pared by completely dissolving 40 mg of plant extract in
200 μL of dimethyl sulfoxide (DMSO) and adding 800
μL of peptone water sugar medium [11]. A stock solu-
tion of the pure compound (4 mg/mL) was prepared
similarly. The MIC was determined by microdilution in a
96-well microtitre plate in duplicate wells as earlier
described [12] with some modifications.
Peptone water sugar (130 μL) was pipetted into each
required well and 50 μL of extract solution added in the
test wells. Positive and negative control wells contained
50 μL of 50 μg/mL gentamycin (12.5 μg/mL gentamycin
final concentration) and 50μL of sterile 0.85% saline re-
spectively. Bacterial suspension (20 μL of 6 × 105 CFUs/
mL) was pipetted into all wells. This gave final concen-
trations of 0.5 - 10 mg/mL of the extract with 5% DMSO
in the highest concentration well. The plate was incu-
bated at 37°C for 24 hours. The lowest concentration
that showed no bacterial growth (no colour change) was
recorded as the MIC. The MIC of the active pure com-
pound was determined using triplicate wells similarly as
for crude extracts at a final concentration range of
50–1000 μg/mL. An aliquot (10 μL) of the MIC wells
that showed no colour change were used to inoculate
the surface of solid nutrient agar and incubated at37°C for 24 hours. The lowest concentration of the
inoculated MIC wells which showed no bacterial
growth was recorded as the MBC.
Toxicity studies
Cytotoxicity of okundoperoxide
The assay was carried out as earlier described [13] with
some modifications using monkey kidney epithelial cells
(LLC-MK2 from ATCC - CCL-7). Different concentra-
tions (0.0078 - 8 mg/mL) of Okundoperoxide, which
demonstrated antibacterial activity, were prepared in
sterile-filtered RPMI-1640 culture medium (SIGMA),
containing 100 μg/mL gentamycin and 2% DMSO final
concentration. Cells were cultured in a 96-well plate.
Prior to testing, the monolayers were washed and the
test done in triplicate wells. Medium (150 μL) was intro-
duced into all required wells. Then 50 μL of each solu-
tion of the compound was pipetted into corresponding
wells. This gave wells with final concentrations of 1.95-
2000 μg/mL of the compound. Positive and negative
control wells contained 0.125 M sodium azide and cul-
ture medium respectively. The plate was incubated at 37°
C and observed for cell death over a period of 6 days.
Dead or deformed cells, usually dark and rounded in
shape, were counted by light microscopy and the LC50
and LC100 values determined graphically.
Acute toxicity of active extracts in mice
The test was conducted as described [14] with some modi-
fication and following the World Health Organization
guidelines for the evaluation of safety and efficacy of herbal
medicines [15]. Equal numbers of male and female Balb/c
mice (21.34± 1.47 g) about 3 months old were used. They
had access to food and water but were deprived of food
15–18 hours prior to the administration of the extracts.
The mice were divided into 3 groups of six. The most ac-
tive extracts of P. vulcanica, i.e. the hexane (PVHEX) and
methylene chloride (PVMC) extracts (840 mg/mL each in
peptone water sugar), were administered to separate
groups of mice twice (i.e. 0.5 mL×2 within 4 hours) giving
a dose of 40 g/kg body weight [equivalent to 10×MIC
(4 mg/mL)], using an oral gauge. The control group
received an equal volume (1 mL) of medium. The mice
were observed for skin changes, mobility, sensitivity to
pain (pinch) and mortality for 7 days. The animals were
weighed before and after the experiment. At the end of the
experiment, all animals were fasted overnight and sacri-
ficed by cranial dislocation.
Statistical analysis of results
The diameter of zones of inhibition of crude extracts is
reported as mean± standard deviation (Table 1). The zones
of inhibition of the active compound (Okundoperoxide)
were reported in terms of percentage efficacy relative to
Table 1 Antibacterial activity of crude extracts of P. vulcanica, P. fernandopoioanaand Scleria striatinux
Zone of inhibition (mm diameter)Ψ
Organisms Positive control PVHEX PVMC PVMeOH PFHEX PFMC PFMeOH SS
E. coli
(ATCC 11775)
GEN 9 ± 1 11 ± 0 10* ± 0 9± 1 11 ± 1 _ 11
25 ± 1




VAN 8 ± 1 7± 0 _ _ 7 ± 1 _ 10*
18 ± 1
S. aureus (Path) GEN 27*, _ 9 ± 1 _ _ 7 ± 0 _ 10*
15 ± 1**
S. typhimurium (Path) VAN _ _ _ _ _ _ _
19 ± 1
P. aeruginosa (Path) GEN _ _ _ _ _ _ _
26 ± 1
Ψ: Zones of inhibition for negative control (acetone) discs were = 0 mm Values are mean ± standard deviation of duplicates for 5 mg extract/disc. PVHEX, PVMC,
PVMeOH = hexane, methylene chloride and methanol extracts of P. vulcanica respectively. PFHEX, PFMC, PFMeoH = hexane, methylene chloride and methanol extract of
P. fernandopoioana respectively, SS =methylene chloride:methanol (1:1) extract of Scleria striatinux, GEN=Gentamycin (1 μg) and VAN = Vancomycin (30 μg).
– = No zone of inhibition observed. * = The outer portion (12 mm) of the whole inhibition zone (27 mm) was unclear. ** = clear inner portion of the whole 27 mm
inhibition zone. Path = clinical isolate.
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[Paired Two Samples for Means (n< 30)], was used to
compare the experimental and control groups of animals
before and after administration of the extracts. The t-
values were calculated using SPSS - 17.0 software. A P
value< 0.05 was considered statistically significant.
Results
Identification of compounds
The hexane and methylene chloride extracts of P. vulcanica
(Figure 1) and P. fernandopoioana (Figure 2) were sub-
jected to bioassay-guided fractionation. The active fractions
were systematically chromatographed on silica gel and/or
Sephadex LH-20 leading to the isolation of 27 compounds.
Two compounds were obtained from Scleria striatinux.
The structures of the isolated compounds (Figure 3)
were determined by comparison of their spectral data
with those reported for Okundoperoxide (1) [7], mataire-
sinol dimethyl ether (2) [16], 5-demethyltangeretin(3)
[17], stigmasterol (4) [18], bursehernin (5) [16], hexade-
canoic acid (6) [19] and linoleic acid (7) [20].
Antibacterial activity of test substances
Crude extracts
All seven plant crude extracts shown on Table 2 were
screened against 6 bacterial test organisms. The diameter
of the zones of inhibition (DZI) ranged from 7–13 mm
(Table 1). The methylene chloride extracts of P. vulcanica,
P. fernandopoioana and the methylene chloride:methanol
(1:1) extract of S. striatinux (SS) were active against 4 of
the 6 test organisms, i.e. the clinical and control strains of
E. coli and S. aureus (Table 1). The hexane extract of P.vulcanica was active against three organisms while the
methanol extract of P. vulcanica and the hexane extract of
P. fernandopoioana were active against two organisms
(Table 1). The methanol extract of P. vulcanica (PVMeOH)
showed an unclear zone of inhibition (UZI, with visible
colony forming units (CFUs) uniformly distributed in the
inhibition zone) against the two E. coli test organisms
(UZI ranging from 9–10 mm), while the methanol extract
of P. fernandopoioana (PFMeOH) was inactive on all the test
organisms. None of the extracts showed activity against
the clinical isolates of S. typhimurium and P. aeruginosa
(Table 1).
Activity of fractions of active crude extracts
Each of the 8 hexane fractions of P. vulcanica showed ac-
tivity against at least one of the 6 test organisms, and the
zones of inhibition ranged from 6–11 mm. The methy-
lene chloride fractions of P. vulcanica that were not
tested in this study will be further investigated subse-
quently. The methanol crude extract was not fractio-
nated due to the weak activity observed from the unclear
zone of inhibition produced (Table 1). For P. fernando-
poioana, a total of 8 hexane fractions and 7 methylene
chloride fractions were screened. Only 4 hexane fractions
showed clear zones of inhibition (DZI ranging 8–11 mm)
against the two strains of S. aureus. Four other hexane
and all seven methylene chloride fractions showed un-
clear zones of inhibition (UZI ranging from 7 - 11 mm)
against S. aureus (ATCC 33862), and the two strains of
E. coli. None of the fractions of P. vulcanica and P. fer-
nandopoioana was active against the clinical isolates
of S. typhimurium and P. aeruginosa. The methanol
Figure 3 Structures of seven of twenty-nine pure compounds isolated and screened for antibacterial activity. Legend: Okundoperoxide
(1) from S. striatinux, the only active compound was bacteriostatic on S. aureus; Matairesinol dimethyl ether (2), 5-Demethyl tangeretin (3), and
Stigmasterol (4) from P. vulcanica; Bursehernin (5), Hexadecanoic acid (6) and Linoleic acid (7) from P. fernandopoioana.
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showed no activity.
Activity of pure compounds
A total of 29 pure compounds from the 3 plants were
screened by the disc diffusion method at 50 to 500 μg/disc.
None of the 13 compounds from P. vulcanica and the 14
from P. fernandopoioana showed activity against any of the
test organisms at the highest amount (500 μg) tested. One
of two compounds from Scleria stiatinux, Okundoperoxide,
inhibited the two strains of S. aureus only. Two clinical iso-
lates of S. aureus, one sensitive to five standard antibiotics
and another resistant to three antibiotics with complete
(100%) resistance to vancomycin (Table 3) identified duringTable 2 Percentage yield (% w/w) of plant extracts




N: not done. N*: partially done for preliminary testing.this study were susceptible to Okundoperoxide (OKP) at
500 μg/disc. OKP showed an efficacy ranging from 61.29 to
135.71% on the sensitive strains relative to five standard
antibiotics; and an efficacy of 35.71 to 71.42% relative to
four antibiotics on an isolate which was completely resist-
ant to vancomycin i.e. DZI=00 mm giving a relative effi-
cacy of >> 100% for OKP compared to vancomycin
(Table 3).
MICs and MBCs of active crude extracts and
okundoperoxide
The MICs of active crude extracts and Okundoperoxide
were determined for organisms on which the test sub-
stances were active. The lowest MIC for the crude extractsExtraction solvent
Hexane Methylene Methanol MC: MeOH
(HEX) chloride (MC) (MeOH) (1:1)
% yield % yield % yield % yield
3.58 3.78 N* N
3.3 2.97 N* N
N N N 11.76
Table 3 Susceptibility of S. aureus to Okundoperoxide and standard antibiotics
Bacterial isolates Zone of inhibition (mm) (% Efficacy of Okundoperoxide)
GEN COL ERY AMP VAN OKP
S. aureus (path) 28 14 27 31 21 19
Sensitive strain (67.86%) (135.71%) (70.37%) (61.29%) (90.48%)
S. aureus 28* 14 24* 14* 00 10*
Resistant strain (35.71%) (71.42%) (41.66) (71.42%) (>> 100%)
GEN=Gentamycin (1 μg), COL=Colistin (10 μg), ERY=Erythromycin (15 μg), AMP=Ampicillin (10 μg), VAN=Vancomycin (30 μg), OKP =Okundoperoxide, isolated from
S. striatinux (500 μg/disc) * = unclear zone of inhibition.
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tents of the MIC wells for both the crude extracts and OKP
which showed inhibition also showed bacterial growth on
solid nutrient agar. Hence no MBC was recorded within the
concentration ranges tested indicating that the active sub-
stances were only bacteriostatic.
Cytotoxicity and acute toxicity
The cytotoxicity assay of Okundoperoxide on monkey kid-
ney cells (LLC-MK2) recorded an LC50 =46.875 μg/mL
and LC100 = 500 μg/mL. For the acute toxicity test, no
death was recorded in both the control and test animals
during the one week study period. However, the mice trea-
ted with the methylene chloride extract of P. vulcanica
showed a group average weight loss of 13.21% which was
statistically significant (P< 0.05) and had scanty fur. On
the contrary, animals in the control group and those trea-
ted with the hexane extract of P. vulcanica gained weight
(+5.01% and +3.54% respectively) but this was not signifi-
cant; no other sign of toxicity was observed.
Discussion
The Peperomias constitute a large genus of herbs widely
distributed in tropical and sub-tropical regions [21]. The
two species used in this study are found around Mount
Cameroon in the South West and in parts of the North
West of Cameroon [22]. Scleria striatinux is also found in
the North West of Cameroon. Crude extracts of the three
plants, P. vulcanica, P. fernandopoioana and S. striatinuxTable 4 Minimum inhibitory concentrations (MICs) of
active extracts and Okundoperoxide
Organisms MIC (mg/mL)
PVHEX PVMC PFMC SS OKP
E. coli (ATCC 11775) 4 4 8 > 10 –
E. coli (Path) 4 4 8 > 10 –
S. aureus (ATCC 33862) 4 4 8 > 10 1
S. aureus (Path) 4 4 8 > 10 1
PVHEX, PVMC = hexane and methylene chloride extracts of P. vulcanica
respectively. PFMC =methylene chloride extract of P. fernandopoioana.
SS =methylene chloride:methanol (1:1) extract of Scleria striatinux.
OKP=Okundoperoxide, isolated from S. striatinux. Path = clinical isolate
(pathological), – = experiment not doneinvestigated in this study all demonstrated antibacterial ac-
tivity against some of the bacterial organisms except for
the methanol extract of P. fernandopoioana. From the flow
charts (Figures 1 and 2), one could observe clear activity
in the fractions of moderate polarity. Both Gram-negative
(E. coli, S. typhimurium and P. aeruginosa) and -positive
bacteria (S. aureus) were selected based on their frequent
occurrence in wounds and implication in common bacter-
ial diseases such as diarrhoea, urinary tract infections and
respiratory tract infections associated with coughing. Four
clinical isolates were sensitive to standard antibiotics and
one was a resistant strain of S. aureus that showed total re-
sistance to vancomycin with a zero diameter of inhibition
and intermediate resistance to erythromycin and ampicillin.
Isolation of a resistant strain in the study area is not unex-
pected given the abusive use of antibiotics which favours
the emergence of resistance as earlier described [23].
Six of the seven crude extracts from the three plants
inhibited two of four bacterial species tested. The methylene
chloride extracts of the Peperomia species and the methy-
lene chloride:methanol (1:1) extract of Scleria striatinux
were the most active (Table 1). Antibacterial activity had
been demonstrated in the crude methanolic extracts of the
whole plant of these two Peperomia species [5]. The earlier
work constituted a basis for this study and our results
confirm their findings and provide further evidence to
support the use of these plants in Cameroonian folk medi-
cine to treat bacterial infections [22]. The methanol extract
of P. fernandopoioana showed no activity against all 6 bac-
terial test organisms, probably due to absence of com-
pounds active against the bacteria following the sequential
extraction performed on the plant powder.
The crude hexane extract of P. vulcanica showed no
activity against the clinical isolate of S. aureus (Table 1).
Interestingly, 3 of the 8 fractions obtained from the hex-
ane extract showed moderate activity against this same
sample with DZI = 10 mm suggesting antagonism be-
tween compounds in the crude extract which could have
been eliminated following fractionation. These fractions
obtained with moderately polar solvents were the most
active with clear zones of inhibition; this suggests that
the bio-active principles in these fractions are moderately
polar. The hexane and methylene chloride extracts of P.
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and S. aureus (Table 1). However, the activity of fractions
from these extracts was not certain given the unclear
zones observed. The latter observation suggests that the
antibacterial action of the crude extracts of this plant
may be due to the combined effect of the compounds
present in them. Upon separation by fractionation, the
antibacterial action was weakened or the active princi-
ples in the fractions were too small to be isolated in suf-
ficiently high amounts to show activity.
Several plants have been reported to display antibacterial
activity on the bacterial species used in this study [24-27].
The current study employed quantities of crude extract
similar to those used in an earlier study and similar zones
of inhibition were recorded, i.e. ranging from 7–15 mm as
against 7–13 mm in this study. Also, much lower MICs
were recorded (32–512 μg/mL against 4 - 8 mg/mL in this
study). This higher activity is likely due to the secondary
metabolites in the plant which was rich in alkaloids, flavo-
noids, phenol, quinines, and terpenoids [24]. Another study
[25] also observed higher activity for six Phyllantus species
having a similar phytochemical profile. The Peperomias
tested in this study contained lignans, steroids, flavonoids
and fatty acids. The difference in phytochemical compos-
ition may largely account for the difference in the reported
activity while other factors such as experimental method
may contribute to a smaller extent. This explanation is
supported by yet similar findings on a plant with a similar
secondary metabolite composition [26]. One of the investi-
gations [27] reported much higher inhibition zones (14 -
36 mm) for the same bacteria species alongside higher
MICs (4–64 mg/mL) and MBCs (8 - 128 mg/mL); these
higher zones may be due to the high amount of extract
(25 mg/disc) used.
Previous studies have shown that most of the common
phytochemical constituents of Peperomia species are phe-
nylpropanoid, benzopyran, chromone, prenylated quinone,
secolignan, and acylcyclohexane-1, 3-dione [21,22]. Some
of these compounds in the crude extracts and fractions of
P. vulcanica and P. fernandopoioana may be responsible for
the antibacterial activities observed.
The isolation of a large number of compounds (27 in
total) from the two Peperomia species is not surprising.
Nineteen compounds were isolated from P. sui of the
same family [21] suggesting that the Piperaceae may be
quite rich in secondary metabolites. Hence, sequential
extraction and bioassay-guided fractionation were done
to narrow down the number of metabolites and increase
our chances of obtaining active compounds. The residual
methanol extracts turned out to be weak or inactive, sug-
gesting that sequential extraction actually localized the
active compounds in the hexane and methylene chloride
extracts (containing moderately polar compounds). How-
ever, none of the compounds from the Peperomiasshowed antibacterial activity, suggesting that the
observed antibacterial activity for some of the crude
extracts and fractions is likely due to the synergistic or
additive interaction of some of these compounds; but
this remains to be demonstrated experimentally.
One of the compounds, Okundoperoxide (OKP), from S.
striatinux showed considerably high activity against a resist-
ant and sensitive strain of S. aureus (Table 3). Considering
the multi-drug resistance that has developed in S. aureus
[2], a bacterium with potentially serious pathology in
humans [28], this activity is therefore highly significant. This
finding provides a strong basis for explorative structure-ac-
tivity relationship studies which may yield new potent anti-
bacterial lead(s) with enhanced activity. Okundoperoxide
had been isolated, its structure determined (Figure 3) and
antiplasmodial activity demonstrated, justifying the use of
the roots of the plant as herbal tea for fevers in Cameroon
[7]. Menthol, a terpenoid isolated from Mentha longifolia L.
leaves showed much higher activity (25 mm zone and MIC
of 15.6 μg/mL) against S. aureus [29]. A higher activity
(MIC=64 μg/mL) was also recorded against S. aureus for
three plant-derived triterpenoids which showed a high de-
gree of synergism with standard antibiotics [30]. The effect
of OKP combined with standard antibiotics should also be
investigated to discover useful combinations with enhanced
antibacterial action to combat resistant bacteria.
The lack of susceptibility in P. aeruginosa and S. typhi-
murium to the crude extracts, fractions or pure com-
pounds may be attributed to several factors including
multi-drug efflux pumps common in P. aeruginosa and
S. typhimurium and the low permeability of the bacterial
envelopes [31]. Efflux pumps extrude the drug from the
cell before they attain an adequate concentration at the
site of action [32]. Some studies have reported no inhib-
ition zone for 24 plant extracts against S. typhimurim
[33] and menthol against P. aeruginosa [29]. Whereas no
antibacterial activity was also reported for 40 plant
extracts against S. typhimurium and S. aureus using the
disc diffusion method, considerable inhibition of these
organisms was recorded using the tube dilution method
[5]. This suggests the tube dilution method may permit a
more rapid accumulation and concentration of active
principles than the diffusion method. The higher concen-
tration of active secondary metabolites obtained with the
tube dilution method would translate into more efficient
inhibition of bacterial growth.
Based on some classifications of antibacterial activity
using the disc method [14,34], the most active extracts
[the methylene chloride extracts of P. vulcanica, P. fer-
nandopoioana, and the methylene chloride:methanol
(1:1) extract of S. striatinux] exhibited moderate activity
(DZI between 11–16 mm). On the same basis, the pure
compound (Okundoperoxide) showed high activity
against S. aureus with a DZI ranging from 10–19 mm.
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(4–8 mg/mL) and the apparently high MBC (> 10 mg/
mL), these plants can be classified as possessing broad-
spectrum bacteriostatic activity. Similarly Okundoperox-
ide with a high MIC of 1 mg/mL may only be bacterio-
static against S. aureus.
The LC50 of Okundoperoxide on monkey kidney cells
(LLC-MK2) was 46.88 μg/mL whereas the active dose was
500 μg/disc i.e. about 10 times the LC50. This suggests OKP
may be toxic to mammalian cells. However, use of different
formulations, disc for antibacterial activity and solution for
cytotoxicity makes comparison of the results difficult as the
rate of distribution of the compound in both experimental
systems is likely to be different. An LC50 =10.02 μg/mL has
been suggested to indicate moderate cytotoxicity [35], while
a CC50> 30 μg/mL has been categorized as non-cytotoxic
[36]. Thus OKP with a higher LC50 can be considered as
having a very low risk of cytotoxicity on mammalian cells.
For P. vulcanica, no mortality was recorded in the acute
toxicity study, suggesting that despite containing a large
number of compounds this plant may be non-toxic to
humans. The changes in body weight of the animals could
have resulted from corresponding changes in feeding due to
alteration of appetite or effects on the metabolism of the
animals.
In conclusion, the observed antibacterial activity of the
two Peperomia species is likely due to the combined effect
of the moderately polar compounds present in them. Fur-
thermore, the apparent lack of acute toxicity in P. vulcanica
supports its use in traditional medicine. In view of its po-
tency and relatively low cytotoxicty, Okundoperoxide may
serve as a template for the development of new antibiotics.
Moreover, given the structural similarity that is found
among the secondary metabolites of a given plant, the iso-
lation of other compounds from S. striatinux may result in
the identification of other interesting antibacterial agents.
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